Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-29 6:27 pm Purchase | 2020-06-17 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 12,714,404 24.400% | 12,714,404 (New Position) | Filing |
| 2020-06-25 8:19 pm Purchase | 2020-06-19 | 13D | Repare Therapeutics Inc. RPTX | ORBIMED ADVISORS LLC | 3,276,325 8.900% | 3,276,325 (New Position) | Filing History |
| 2020-06-11 4:25 pm Sale | 2020-06-09 | 13D | BELLUS Health Inc. BLU | ORBIMED ADVISORS LLC | 3,954,800 6.600% | -988,616 (-20.00%) | Filing History |
| 2020-06-04 4:58 pm Sale | 2020-06-02 | 13D | Alector, Inc. ALEC | ORBIMED ADVISORS LLC | 6,466,992 8.200% | -1,395,400 (-17.75%) | Filing History |
| 2020-05-26 4:40 pm Purchase | 2020-05-21 | 13D | scPharmaceuticals Inc. SCPH | ORBIMED ADVISORS LLC | 4,797,148 17.900% | 1,387,283 (+40.68%) | Filing History |
| 2020-05-22 4:54 pm Sale | 2020-05-20 | 13D | Ascendis Pharma A/S ASND | ORBIMED ADVISORS LLC | 2,083,713 4.300% | -435,069 (-17.27%) | Filing History |
| 2020-05-22 4:54 pm Unchanged | 2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX | ORBIMED ADVISORS LLC | 2,027,550 4.900% | 0 (Unchanged) | Filing History |
| 2020-05-20 4:54 pm Purchase | 2020-05-06 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 14,014,321 77.700% | 2,400,000 (+20.66%) | Filing History |
| 2020-05-07 9:48 pm Sale | 2020-05-05 | 13D | Ascendis Pharma A/S ASND | ORBIMED ADVISORS LLC | 2,518,782 5.200% | -493,118 (-16.37%) | Filing History |
| 2020-05-01 4:15 pm Purchase | 2020-04-28 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,765,717 9.200% | 2,765,717 (New Position) | Filing History |
| 2020-04-17 4:13 pm Purchase | 2020-03-20 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,767,584 24.200% | 142,656 (+2.15%) | Filing History |
| 2020-04-17 4:07 pm Purchase | 2020-04-08 | 13D | Keros Therapeutics, Inc. KROS | ORBIMED ADVISORS LLC | 1,268,734 6.300% | 1,268,734 (New Position) | Filing History |
| 2020-04-16 8:15 pm Sale | 2020-04-14 | 13D | Alector, Inc. ALEC | ORBIMED ADVISORS LLC | 7,862,392 10.000% | -853,952 (-9.80%) | Filing History |